Navigation Links
Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
Date:10/26/2010

d to treatment with Zerenex during the safety assessment will be randomized to continue treatment with either Zerenex or placebo for a 4-week period.

About Special Protocol Assessments

The Special Protocol Assessment (SPA) process is a procedure by which the FDA provides official evaluation and written guidance on the design and size of proposed protocols that are intended to form the basis for a new drug application.

Final marketing approval depends on the results of efficacy, the adverse event profile and an evaluation of the benefit/risk of treatment demonstrated in the Phase 3 clinical program. The SPA agreement may only be changed through a written agreement between the sponsor and the FDA, or if the FDA becomes aware of a substantial scientific issue essential to product efficacy or safety. For more information on Special Protocol Assessment, please visit: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm080571.pdf.

About Hyperphosphatemia

In the United States, according to data from the U.S. Renal Data System, there are approximately 485,000 patients with end-stage renal disease, or ESRD, and the number of ESRD patients is projected to rise 60% to approximately 785,000 by 2020. The majority of ESRD patients, close to 400,000, require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization.  ESRD patients usually require treatment with phosphate-binding agents to lower and maintain serum phosphorus at acceptable levels. The need for alternative phosphate-binding agents has long been recognized, especially given the increasing prevalence of ESRD as well as shortcomings with
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
3. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
4. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma
7. Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
8. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
11. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pomerantz LLP is investigating claims on ... the "Company") (NASDAQ: VTAE ).  Such investors ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... its officers and/or directors have violated Sections 10(b) and ... On February 27, 2015, the Company announced ...
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers ... board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ... per share. Concerned SLXP investors are encouraged to contact ... The investigation focuses upon the shareholder value ... Salix shareholders would receive only $158.00 per share in ...
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... Varian Medical Systems, Inc. (NYSE: VAR ), ... cancer with radiotherapy, announced today it has received Shonin ... Welfare (MHLW) to market the TrueBeam™ system for image-guided ... of lung, breast, prostate, head and neck, and other ...
... June 15, 2011 Reportlinker.com announces that a ... catalogue: US Cardiac Assist Devices ... http://www.reportlinker.com/p0555154/US-Cardiac-Assist-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices Short ... vital market data on the cardiac assist devices ...
Cached Medicine Technology:TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval 2TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval 3Reportlinker Adds US Cardiac Assist Devices -- Market Trend Till 2016 2Reportlinker Adds US Cardiac Assist Devices -- Market Trend Till 2016 3
(Date:3/1/2015)... New York, New York (PRWEB) March 01, 2015 ... Wright Profemur hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled ... that the defense must prepare a witness to ... implant played in the development of the Profemur ... Order filed in U.S. District Court, Northern District ...
(Date:3/1/2015)... The number of transvaginal mesh lawsuits ... few weeks in two New Jersey litigations where attorneys ... Firm announces. , A Case List updated on ... County proceeding established for products manufactured by Johnson & ... earlier, when 90 fewer cases had been centralized. Additionally, ...
(Date:3/1/2015)... March 01, 2015 ERISAPros ... and Carolyn Roddy to the professional staff of its ... graduated from The Ohio State University-Mortiz College of Law. ... of experience working with several Fortune 500 companies as ... area of corporate benefits. Her experiences range from benefit ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... Malaysia (PRWEB) February 28, 2015 The ... all across Malaysia into one platform and gears towards ... , A series of group talks in smaller ... like Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, ... and raise awareness of Malaysian youths. , ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4
... & Master Aesthetician in partnership with Medical Director, Betsy Vasquez, MD announced ... in Leesburg, VA, located at the Fort Evans Plaza II. ... ... and Medspa visionary announced today that AVIE! Medspa and Laser Center is ...
... that Gov. Kathleen Sebelius, nomination to Health and ... end of April, American Life League called on ... reject the nomination.(Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ... longstanding Senate tradition only confirming nominees if their ...
... The fruit, combined with contraceptive pill and a genetic ... THURSDAY, April 2 (HealthDay News) -- A rare set ... a genetic mutation almost cost a 42-year-old woman her ... driving in the car one afternoon," said Dr. Lucinda ...
... AMICAS, presence in the image and information management marketBOSTON, ... ) a leader in radiology and medical image and ... the acquisition of Emageon Inc. (Nasdaq: EMAG ... )"AMICAS and Emageon have a shared vision that ...
... MSU chemist Kevin Walker describes how he uses enzymes to make anti-cancer drug paciltaxel. , ... more information. , , , ... , , , ... , , , , ...
... April 2 Streamline Health Solutions, Inc. (Nasdaq: ... and fiscal year 2008 financial results for the period ended ... market closes. The Company will conduct a conference call ... 9 at 4:30 p.m. ET.Interested parties can access the call ...
Cached Medicine News:Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 3Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:AMICAS Announces Completion of Merger with Emageon 2Health News:AMICAS Announces Completion of Merger with Emageon 3Health News:AMICAS Announces Completion of Merger with Emageon 4Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 2Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 3Health News:Streamline Health to Announce Q4 and Fiscal Year 2008 Financial Results on Thursday, April 9, 2009 2Health News:Streamline Health to Announce Q4 and Fiscal Year 2008 Financial Results on Thursday, April 9, 2009 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: